TREA

97775859 - YORHAEVEN

Follow

Information

  • Trademark
  • 97775859
  • Serial Number
    97775859
  • Filing Date
    February 01, 2023
    2 years ago
  • Transaction Date
    September 19, 2024
    6 months ago
  • Status Date
    September 18, 2024
    6 months ago
  • Published for Opposition Date
    August 20, 2024
    7 months ago
  • Location Date
    July 18, 2024
    8 months ago
  • Status Code
    802
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MARTIN, LIEF
  • Attorney Docket Number
    034845.366
    Attorney Name
    Scott D. Woldow
    Law Office Assigned Location Code
    M30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
YORHAEVEN
Case File Statements
  • GS0051: Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; blood for medical purposes; cell cultures for medical purposes, namely, cells for medical or clinical use; cell cultures for medical purposes, namely, living cells for medical use; cell cultures for medical purposes, namely, stem cells for medical or veterinary use; pharmaceutical preparations for the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza; Pharmaceutical preparations, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; pharmaceutical preparations, namely, antibody for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations, namely, antibody for the treatment of Hereditary Angioedema, HAE
Case File Event Statements
  • 10/29/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/7/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/7/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/27/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/29/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/29/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/29/2024 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/17/2024 - 8 months ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/17/2024 - 8 months ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/17/2024 - 8 months ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/17/2024 - 8 months ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 9/18/2024 - 6 months ago
    15 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 8/20/2024 - 7 months ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/31/2024 - 8 months ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/20/2024 - 7 months ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO